104 related articles for article (PubMed ID: 8333508)
1. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells.
Sandouk T; Reda D; Hofmann C
Am J Physiol; 1993 Jun; 264(6 Pt 1):C1600-8. PubMed ID: 8333508
[TBL] [Abstract][Full Text] [Related]
2. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability.
Sandouk T; Reda D; Hofmann C
Endocrinology; 1993 Jul; 133(1):352-9. PubMed ID: 8319581
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
Kletzien RF; Clarke SD; Ulrich RG
Mol Pharmacol; 1992 Feb; 41(2):393-8. PubMed ID: 1538716
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.
Szalkowski D; White-Carrington S; Berger J; Zhang B
Endocrinology; 1995 Apr; 136(4):1474-81. PubMed ID: 7895657
[TBL] [Abstract][Full Text] [Related]
5. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H
Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
7. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
[TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
de Souza CJ; Eckhardt M; Gagen K; Dong M; Chen W; Laurent D; Burkey BF
Diabetes; 2001 Aug; 50(8):1863-71. PubMed ID: 11473050
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.
Hallakou S; Doaré L; Foufelle F; Kergoat M; Guerre-Millo M; Berthault MF; Dugail I; Morin J; Auwerx J; Ferré P
Diabetes; 1997 Sep; 46(9):1393-9. PubMed ID: 9287037
[TBL] [Abstract][Full Text] [Related]
11. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes.
Wu Z; Xie Y; Morrison RF; Bucher NL; Farmer SR
J Clin Invest; 1998 Jan; 101(1):22-32. PubMed ID: 9421462
[TBL] [Abstract][Full Text] [Related]
13. Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243.
Burkey BF; Dong M; Gagen K; Eckhardt M; Dragonas N; Chen W; Grosenstein P; Argentieri G; de Souza CJ
Metabolism; 2000 Oct; 49(10):1301-8. PubMed ID: 11079820
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
[TBL] [Abstract][Full Text] [Related]
15. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
Hofmann CA; Edwards CW; Hillman RM; Colca JR
Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.
Dello Russo C; Gavrilyuk V; Weinberg G; Almeida A; Bolanos JP; Palmer J; Pelligrino D; Galea E; Feinstein DL
J Biol Chem; 2003 Feb; 278(8):5828-36. PubMed ID: 12486128
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.
Ohsumi J; Sakakibara S; Yamaguchi J; Miyadai K; Yoshioka S; Fujiwara T; Horikoshi H; Serizawa N
Endocrinology; 1994 Nov; 135(5):2279-82. PubMed ID: 7956951
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.
Smith U; Gogg S; Johansson A; Olausson T; Rotter V; Svalstedt B
FASEB J; 2001 Jan; 15(1):215-220. PubMed ID: 11149909
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glucose transport by pioglitazone in cultured muscle cells.
el-Kebbi IM; Roser S; Pollet RJ
Metabolism; 1994 Aug; 43(8):953-8. PubMed ID: 8052151
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent.
Kletzien RF; Foellmi LA; Harris PK; Wyse BM; Clarke SD
Mol Pharmacol; 1992 Oct; 42(4):558-62. PubMed ID: 1435736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
